Multiple sclerosis (MS) results in cognitive impairment in approximately half of affected individuals 1 . These deficits can occur very early in the disease course; sometimes even as the initial presenting symptom before a formal diagnosis can be made 2, 3 . Although much individual variability exists, domains affected often include: attention and information processing speed, memory, visual perception and executive functioning 4 . Studying these deficits is important given the strong negative impact on quality of life 5 . Cognitive deficits often progress over time, although the rate of progression is slow, with changes being detectable in only a subset of individuals, and only after intervals of at least three years 6, 7 . Amato et al 8 examined both cross-sectional and longitudinal studies. On the basis of their review they concluded that cognitive dysfunction is highly prevalent and that secondary-progressive subtypes may develop greater cognitive ABSTRACT: Objective: To determine if different methods of evaluating cognitive change over time yield measurably different outcomes. Methods: Twelve cognitively impaired patients with clinically definite Multiple sclerosis (10 relapsing-remitting, 2 secondary progressive) underwent neuropsychological testing (baseline, 6, 12 months). Data was analysed using: t-tests evaluating group differences on individual tests, group differences in composite scores, reliable change analyses at the level of the individual, and comparisons regarding number of tests failed at each time point. Results: Group t-tests on individual tests yielded no change. When tests were grouped according to theoretical constructs, analyses revealed change in processing speed. Reliable change estimates revealed that 16% of the sample deteriorated. When change was measured with respect to the number of domains affected at each time point, 58% of the sample deteriorated on at least one subtest. Conclusions: Methodology has a significant impact on interpretation of longitudinal data. In the same group of subjects, traditional group analyses documented no change in individual test scores or change on a single composite score. Analyses of individual results documented change from 16 to 58% of the sample. Advantages and disadvantages of each method were discussed. Findings have implications for interpretation of longitudinal studies.
Multiple sclerosis (MS) results in cognitive impairment in approximately half of affected individuals 1 . These deficits can occur very early in the disease course; sometimes even as the initial presenting symptom before a formal diagnosis can be made 2, 3 . Although much individual variability exists, domains affected often include: attention and information processing speed, memory, visual perception and executive functioning 4 . Studying these deficits is important given the strong negative impact on quality of life 5 . Cognitive deficits often progress over time, although the rate of progression is slow, with changes being detectable in only a subset of individuals, and only after intervals of at least three years 6, 7 . Amato et al 8 examined both cross-sectional and longitudinal studies. On the basis of their review they concluded that cognitive dysfunction is highly prevalent and that secondary-progressive subtypes may develop greater cognitive
The choice of appropriate statistical methodology when measuring change in cognition over time has been a focus in many areas of study within the neuropsychological literature [10] [11] [12] [13] [14] [15] [16] [17] . This has been addressed with regard to the cognitive effects of adjuvant chemotherapy 18 , sport-related concussion 19 , other types of traumatic brain injury 20 , epilepsy surgery 21 , and dementia 22 to name but a few. There has been less discussion of methodological issues in the MS literature. Outside of largescale epidemiological studies, the majority of researchers choose to evaluate longitudinal change by evaluating group differences between baseline and follow-up using t-tests, analysis of variance, or correlational techniques.
In his 2003 chapter, Chelune 11 reviewed factors that must be considered when assessing change over time. The first of these is bias or systematic change in performance; the most common being a positive practice effect. In circumstances where prior exposure to a particular test causes one to perform better with a second exposure, interpretation of the findings can be difficult. Even if no change in scores is documented, this may represent an actual decrement in performance. Many neuropsychological tests are susceptible to the effects of practice in both patient and control samples. Other potential sources of bias include: participant variables (e.g. aging, ability, mood, medications), test variables (e.g. reliability, floor/ceiling effects) and duration of the test-retest interval. The second factor to consider when assessing change over time is error 11 . In statistical language this is called the standard error of measurement (SE M ; the distribution of random variations in a test score around a true score). Another form of error is regression to the mean. This is the tendency for follow-up scores to regress to the mean of the scores from the first distribution. Thus, if a score is spuriously high when first measured, upon retest the natural tendency would be for the score to be lower. The opposite is true for initial measurements that are spuriously low. Assessment tools that have low reliability are more likely to yield retest scores that regress back to the mean. This clearly results in difficulties interpreting findings.
Techniques to address these issues are embedded in traditional statistical methods used to assess group differences (e.g. t-tests for correlated groups; repeated measures ANOVA). However, when one considers the test performance of a particular individual, different statistical techniques are required. Two main statistical methods that have been utilized to measure change over time at the level of the individual are: Reliable Change Index (RCI) and Standardized Regression Based Change Scores (SRB). The two techniques vary in their ability to address the above measurement problems.
The RCI method was first introduced by Jacobson and Truax 23 when assessing change in individuals after psychotherapy treatment. The significance of the change in an individual test score is based on the difference between the baseline and retest scores for the normative subject sample. This allows the estimation of the distribution of expected change based on information found in test manuals. A change is considered unlikely to occur by chance (i.e. reliable) "if the absolute value of this change exceeds the standard deviation of the test-retest differences in the norming sample, multiplied by the z-score cut point that defines a designated percentile in the normal distribution" 16 . Because the initial RCI method was developed to evaluate change following psychotherapy, there was no consideration of practice effects, such as those encountered when a subject is retested using a cognitive measure to which they have prior exposure. Initial attempts to address this used a "constant" value for practice 14, 21 but this does not consider regression to the mean. Based on suggestions by Iverson, the method was further adapted by Chelune and colleagues 24 given that measurement error may be different at baseline than at retest. Others have adapted the RCI method further by using linear regression of the retest scores on the baseline scores in the norming sample. A formula is generated that allows prediction of retest scores from any baseline score 25 . This method considers both practice and regression to the mean.
As noted, one of the problems with RCI methods is that they treat practice as a constant. However, research has demonstrated that practice effects can differ. For example, individuals with average to high average intellectual capabilities may be able to benefit more from practice than those with low average capabilities 26 . Chelune 11 also notes that the degree of change noted over time may also be impacted by the length of the testretest interval and demographic factors such as age, education, and gender. The SRB techniques take into account measurement error, regression to the mean, differential practice effects and demographic variables. These multiple potential predictors of retest scores can be included in a multivariate regression model. Although theoretically, the regression-based techniques may be more advantageous 16 , Heaton and his colleagues 12 found that classification rates of "change" or "no change" did not differ substantially between the two methods. They concluded that the simpler RCI methods that consider practice were likely more justified.
The objective of the current project was to determine if different methods of evaluating cognitive change over time yield measurably different outcomes in a sample of cognitively impaired patients with multiple sclerosis. Traditional group comparisons between baseline and retest performance were completed both for individual measures as well as composite scores grouping tests measuring similar constructs. In addition, RCI analyses (with corrections for practice) were completed to provide information on change over time in particular individuals. Finally, the method utilized by Amato and colleagues 9 , which examined the number of tests failed at retest as compared to baseline, was also used.
METHOD

Subjects
Twelve patients with cognitive impairment, in the absence of major physical disability, were included in the analyses. Ten were diagnosed with relapsing-remitting MS and two with secondary progressive MS. Mean age was 47.3 (4.5) years (range 41-55), with a mean level of education of 15.1 (2.7) years (range [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . At baseline, the average number of years since diagnosis was 9.7 (6.6) (range 1-26), with an average time since last relapse of 4.2 (1.3) months (range 2-5). All patients were recruited through the MS Clinic of the Ottawa Hospital. All presented with cognitive impairment as assessed by their neurologist, themselves, or a close friend or relative.
Procedure
Informed consent form was obtained and patients were given a structured demographic interview. All completed a comprehensive neuropsychological assessment battery at baseline, 6 months and 12 months. Participants also underwent neuroimaging but these findings are beyond the scope of the current article 27 39 .
Data Analyses
Group differences: individual test scores
Paired-sample t-tests were performed on raw scores to evaluate group differences at baseline vs. 6 months, baseline vs. 12 months, and 6 months vs. 12 months. Corrections were made to statistically control for multiple comparisons.
Group differences: composite scores
Selected tests were grouped into four areas of cognition that are often affected in individuals with MS (see Table 1 ). Pairedsample t-tests were performed on composite scores (z-scores) to evaluate group differences at baseline vs. 6 months, baseline vs. 12 months, and 6 months vs. 12 months. Corrections were made to statistically control for multiple comparisons.
Individual differences: Reliable Change Index
A variation of the RCI was used that included an adjustment for practice effects that result from serial testing 18 .
RCI = (SEdiff) (+/-1.64) + practice effect
The SEdiff is the standard error of the difference which represents the spread of distribution of change scores expected had no change occurred. The practice effect for each variable is the mean difference between the follow-up and baseline scores. Difference scores were calculated for each subject on each measure (T2-T1, T3-T2, T3-T1). The difference scores were considered to be statistically significant and reliable at 90% confidence intervals if the degree of change fell outside the values derived from the RCI formula. Those subjects who demonstrated declines on two or more subtests were considered to have demonstrated reliable cognitive change.
Comparison of number of tests failed
Rather than focus on change in particular cognitive domains, Amato et al, 9 evaluated whether individuals with MS demonstrated deterioration in cognition overall (regardless of domain). When examining whether or not a relationship existed between cognition and neocortical volume loss, they compared the number of cognitive tests failed at each time point. A test was considered failed if a subject scored 2 or more standard deviations below the mean derived from a normative sample. For the purposes of the current paper, liberal criteria were used such that a test was considered failed if any subscale score fell below the mean by 2 or more standard deviations. Table 2 lists the unadjusted means and standard deviations on all measures at baseline, 6 months and 12 months. It is important to note that small practice effects were found on almost all cognitive measures.
RESULTS
Group differences: individual test scores
Group t-tests for scores on individual tests yielded no significant change over time.
Group differences: composite scores
When tests were grouped together according to four different theoretical constructs, analyses of resulting composite scores revealed a change in processing speed between baseline and 12 months (t(9) = -3.81, p < .01). All other comparisons were nonsignificant. Subjects demonstrated faster processing speed at 12 months compared to baseline.
Individual differences: Reliable Change Index
At the level of the individual, subtle cognitive losses were observed in two subjects (16% of sample). Demographic and clinical characteristics of these subjects did not differ from the overall sample. Cognitive decline was noted on measures of processing speed, memory, and executive function. Measures most helpful in identifying cognitive decline included: CVLT -II (short form; total immediate recall, short-delay free recall, long-delay free recall), phonemic fluency and semantic fluency tasks (see Figure for an example of the semantic fluency findings). 
Composite Domain Tests included
Comparison of number of tests failed
The methodology of Amato et al 9 revealed that 50% of subjects demonstrated a greater number of failed tests between baseline and six months, and 58% showed a greater number of failed tests between baseline and 12 months (see Table 3 ).
DISCUSSION
Current data could be interpreted as documenting no change, improvement (information processing speed), or deterioration (in a minority [16%] or a majority [58%] of subjects). This has implications for interpretation of longitudinal studies, such as when neuropsychological findings are used as outcome measures in clinical trials. There is potential for prejudice in interpretation. Each method has advantages and limitations. This paper is not meant to champion any particular method. Rather, the intention is to highlight the need to attend to methodology and consider the implications when interpreting findings.
Group analyses on individual tests are useful when attempting to measure change that occurs relatively uniformly in a sample. However, they are susceptible to increased Type I error given the multiple comparisons. In relation to MS research, the significant individual variability, which is a hallmark feature of MS, can be masked. It is difficult to identify particular subpopulations that may be vulnerable to cognitive decline when evaluated in the context of other populations that are less likely to demonstrate decline. For example, individuals with MS who present with cognitive impairment at baseline, are more likely to demonstrate cognitive decline over time when compared to those who are cognitively intact 40 . Group analysis of change may overlook such variations.
Although grouping tests according to constructs is theorydriven, individual tests included are not necessarily measuring the same construct to the same degree. In addition, most tests lack purity in that they encompass cognitive skills from multiple domains. In the current study, there was a counter-intuitive improvement in processing speed over time. Given that this group analysis did not take into account practice (comparisons to a control group were not possible), less confidence can be placed in the findings, raising questions about the value of the analysis. Although statistically significant, the finding is not likely clinically meaningful.
Analysing results at the level of the individual using reliable change methodology has the advantage of factoring out effects of practice and providing a measure of statistically meaningful change. This methodology is well suited to longitudinal research with serial testing. It is particularly relevant to MS research given that it allows individual variability to be accounted for, while still doing so in a statistically robust manner. Although this method is well-suited to small sample sizes, it is cumbersome with larger samples, and again is susceptible to increased error associated with multiple comparisons. Iverson et al 41 highlight that RCI calculations raise the question of whether researchers should favour sensitivity or specificity. By establishing 90% confidence intervals for reliable change, this may lead to the conclusion that no change has occurred in those who have not reached this criteria. Thus, individuals may not demonstrate statistically meaningful change, but could very well show clinically meaningful change sufficient to impact quality of life. This may be particularly true for individuals who show only subtle changes that may seriously impair their ability to perform cognitively demanding jobs. Iverson et al 41 emphasized that "reliable change difference scores are meant to supplement, not replace, clinical judgment", thus real change should not be ignored clinically simply because it does not meet stringent statistical criteria.
Although the methodology utilized by Amato et al 9 was able to detect "more" change in the current sample than other methods discussed above, the specific criteria utilized may impact how clinically meaningful these changes are. Although they noted that a test was considered "failed" if a subject scored ≥ 2 standard deviations below the mean, it is unclear what "score" they used. Currently, a test was considered "failed" if any sub-score met the criteria. The subject could potentially have performed better on other aspects of the test. Base rate research shows that even healthy controls are likely to perform poorly on one or more measures within a battery of tests. Heaton et al 12 note that adequate interpretation of findings can occur only if the neuropsychologist is aware of how many changes of a given magnitude are likely to occur when a particular test battery is administered to a group of neurologically healthy individuals. This highlights the need for normative data for groups of tests when used together 42 . Specific batteries geared to MS are in widespread use (e.g. Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis 43 ; Minimal Assessment of Cognitive Function in MS 44, 45 ) , so this suggestion is certainly a feasible one. Using the methodology of Amato et al 9 with liberal guidelines for "failure" (i.e. failure of one subtest rather than failure on all subtests) may overestimate the prevalence of cognitive deterioration associated with MS, as it likely did in our sample. If stricter criteria were used so that tests were considered failed only if all subtest scores fell below a cutoff, then the opposite could be true (i.e.estimates of cognitive deterioration could also be underestimated). It is unclear how stringent the criteria were in the original paper 9 . Consideration of the number of tests failed at different time points provides unique information about changes in the extent of impairment (i.e. across cognitive domains). Ingraham and Aiken 46 stress that in a clinical context practitioners need to consider not only the number of failed tests but also the extent of the impairment and the types of tests that demonstrate impairment. Data becomes more meaningful when the risks and benefits of documenting change for individual patients are considered. This is particularly relevant when evaluating change as an outcome measure in clinical trials. If a negative change was falsely detected, then patients may be denied a treatment that could potentially be beneficial. Alternatively, if positive change was falsely detected patients could be offered a treatment that is essentially ineffective.
One advantage of the Amato et al 9 method over the others discussed in this paper is that individual scores are standardized and compared to normative data. Thus, whereas the first three methods assess absolute change over time, the fourth assesses relative change in comparison to a healthy population. Thus, whereas the first three methods may document change even when it does not represent a true transition into a pathological or abnormal cognitive state, the fourth can confirm whether or not true cognitive abnormality is present. Clearly then, this adds to the meaningfulness of the findings given that the information is more clinically relevant.
CONCLUSION
Although the data from the current study are interesting, one should exercise caution before drawing from it conclusions about cognition in MS in general. The small sample size certainly limits the generalizability of the findings. However, the main purpose of this paper was to generate awareness in the MS field of how important it is to consider methodology. The intent was not to promote the use of one method over another, but rather to highlight that each method has implications for interpretation of outcomes. Consumers of research must be vigilant to statistical methods and consider the associated advantages and limitations before generalizing conclusions. Given the limitations of the current study with regard to both sample size and heterogeneity of subjects, future studies should attempt a similar comparison of statistical methodologies with a larger and more homogeneous sample. Application of this approach to other neurological populations may similarly raise awareness of methodological issues and the resulting implications for outcome measurement.
